Comprehensive Evaluation of Ocular Toxicity of Topical Levofloxacin in Rabbit and Primate Models

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 23, Issue 1, 2004, Pages 1-18

  Clark, Leslie ^a   Bezwada, Padma ^a   Hosoi, Kazuhiro ^a   Ikuse, Toshimi ^a   Adams, Steven ^b   Schultz, Gregory S ^c   O'Brien, Terrance ^d  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Levofloxacin; Ocular toxicity; Ofloxacin; Primate; Quinolone; Rabbit

Indexed keywords

EYE DROPS; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMOSIS; CONTROLLED STUDY; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA THICKNESS; DOSE RESPONSE; DRUG INSTILLATION; EYE INJURY; EYE IRRITATION; EYE TOXICITY; FEMALE; MALE; NONHUMAN; PRIMATE; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS; PRIMATES; VERTEBRATA;

EID: 1542427150     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-120029762     Document Type: Article

References (13)

1. Davis R, Bryson HM. Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994; 47:677-700.
2. Hayakawa I, Atarashi S, Yokohama S, et al. Synthesis and antimicrobial activities of optically active ofloxacin. Antimicrob Agents Chemother 1986; 29:163-164.
3. Langtry HD, Lamb HM. Levofloxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs 1998; 56:487-515.
4. Owens RC Jr, Ambrose PG. Clinical use of the fluoroquinolones. Med Clip North Am 2000; 84:1447-1469.
5. max as a pharmacokinetics parameter of ophthalmic solution. J Eye 1995; 12:783-786.
6. Shigeyuki F, Fumihiko I. Studies on ocular irritation by topical ocular application (1) immediate irritability of various compounds and ocular damages by repeated applications. Gendai no rinsyou 1970; 4:277-289.
7. Brightwell J, Eiferman RA, Valenzuela P, Barr PJ, Merryweather JP, Schultz GS. Acceleration of corneal wound healing in primates by human epidermal growth factor. Invest Ophthalmol Vis Sci 1885; 26:105-110.
8. Wimer SM, Schoonover L, Garrison MW. Levofloxacin: a therapeutic review. Clip Ther 1998; 20:1049-1070.
9. Patel GM, Chuang AZ, Kiang E, Ramesh N, Mitra S, Yee RW. Epithelial healing rates with topical ciprofloxacin, ofloxacin, and ofloxacin with artificial tears after photorefractive keratectomy. J Cataract Refract Surg 2000; 26:690-694.
10. Nelson JD, Silverman V, Lima PH, Beckman G. Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics. Curr Eye Res 1990; 9:277-285.
11. Mallari PL, McCarty DJ, Daniell M, Taylor H. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001; 131:131-133.
12. Moreira LB, Lee RF, de Oliveira C, LaBree L, McDonnell PJ. Effect of topical fluoroquinolones on corneal re-epithelialization after excimer laser keratectomy. J Cataract Refract Surg 1997; 23:845-848.
13. Bezwada P, Clark L, Adams S, O'Brien T, Schultz GS. Comparative ocular bioavailability and efficacy of topical levofloxacin and ofloxacin in rabbits. J Toxicol Cutaneous Ocular Toxicol. Submitted.